English
Specials
    Upgrade

    Moneycontrol

    Budget 2023Budget 2023

    PARTNERS

    • Tata AIA Life Insurance
    • Hafele
    • Motilal Oswal
    Open for all to watch : Nifty Banker 3.0 | Watch Day 12 Session today by Ashok Devanampriya at 8pm.
    Budget 2023
    Budget 2023
    you are here: HomeNewsPhotosBusinessStocks

    Gainers & Losers: 10 stocks that moved the most on January 27

    PSU Bank, oil & gas, power and metal indices were down 4-6 percent. The BSE midcap index shed 1.2 percent and smallcap index declined 1.9 percent

    Sandip Das
    January 27, 2023 / 04:14 PM IST
    Benchmark indices ended lower on January 27 with Nifty around 17600. At close, the Sensex was down 874.16 points or 1.45% at 59,330.90, and the Nifty was down 287.70 points or 1.61% at 17,604.30.
    1/11
    The benchmark indices ended deep in the red on January 27 as selling continued unabated. At close, the Sensex was down 874.16 points or 1.45% at 59,330.90, and the Nifty was down 287.70 points or 1.61% at 17,604.30.
    Tata Motors | CMP: Rs 445.25 | The scrip jumped over 6 percent after the auto major reported a consolidated net profit of Rs 2,957.71 crore for the quarter ended December 2022, against a loss of Rs 1,516.14 crore in the same quarter last year. Revenue from operations came in at Rs 88,488.59 crore, up 22.51 percent from Rs 72,229.29 crore in the same quarter last year, Tata Motors said in an exchange filing.
    2/11
    Tata Motors | CMP: Rs 445.25 | The scrip jumped more than 6 percent after the auto major reported a consolidated net profit of Rs 2,957.71 crore for the quarter ended December 2022 against a loss of Rs 1,516.14 crore in the same quarter last year. Revenue from operations came in at Rs 88,488.59 crore, up 22.51 percent from Rs 72,229.29 crore in the same quarter last year, Tata Motors said in an exchange filing.
    Gland Pharma | CMP: Rs 1,355 | The share price ended in the green in weak market conditions. United States Food and Drug Administration (US FDA) conducted an inspection at the Company’s API Facility at JNPC, Visakhapatnam from January 23, 2023 to January 27, 2023 and has been completed with Zero observations, the firm said.
    3/11
    Gland Pharma | CMP: Rs 1,355 | The share price ended in the green in weak market conditions. The United States Food and Drug Administration (US FDA) conducted an inspection at the company’s API Facility at JNPC, Visakhapatnam from January 23, 2023 to January 27, 2023 and was completed with zero observations, the firm said.
    Patanjali Foods | CMP: Rs 1,104.20 | The stock hit 5 percent lower circuit on January 27. Patanjali Foods has reported a 16% year-on-year increase in profit at Rs 269.2 crore for December FY23 quarter despite weak operating performance, aided by higher topline, other income and lower finance cost. Revenue grew by 26.2% YoY to Rs 7,927 crore compared to year-ago period. EBITDA was down by 12.4% to Rs 368 crore compared to corresponding period last fiscal.
    4/11
    Patanjali Foods | CMP: Rs 1,104.20 | The stock hit 5 a percent lower circuit on January 27. Patanjali Foods has reported a 16% year-on-year increase in profit at Rs 269.2 crore for the December FY23 quarter despite a weak operating performance, aided by higher topline, other income and lower finance cost. Revenue grew by 26.2% YoY to Rs 7,927 crore compared to the year-ago period. EBITDA was down by 12.4% to Rs 368 crore compared to the corresponding period last fiscal.
    Chennai Petroleum Corporation | CMP: Rs 242.50 | The share price jumped over 5 percent after the company reported a 751% sequential rise in consolidated profit at Rs 144.2 crore for quarter ended December FY23, driven by healthy operating performance. Consolidated revenue at Rs 16,054 crore for the quarter increased by 18% over previous quarter.
    5/11
    Chennai Petroleum Corporation | CMP: Rs 242.50 | The share price jumped over 5 percent after the company reported a 751% sequential rise in consolidated profit at Rs 144.2 crore for the quarter ended December FY23, driven by healthy operating performance. Consolidated revenue at Rs 16,054 crore for the quarter increased by 18% over the previous quarter.
    Glenmark Pharma | CMP: Rs 382.20 | The scrip shed over 4 percent on January 27. The company has posted net profit at Rs 105 crore in the quarter ended December 2022 versus Rs 104 crore and revenue was up 3.5% at Rs 540.7 crore against Rs 522.5 crore, YoY.
    6/11
    Glenmark Pharma | CMP: Rs 382.20 | The scrip shed over 4 percent on January 27. The company posted a net profit at Rs 105 crore in the quarter ended December 2022 against Rs 104 crore in the year-ago period. Revenue was up 3.5% YoY at Rs 540.7 crore from Rs 522.5 crore.
    Dr Reddy's Laboratories | CMP: Rs 4,312.45 | The stock price added over 2 percent after research house Macquarie kept ‘Outperform’ rating on the stock with a target at Rs 4,915 per share as Q3 revenue/EBITDA/PAT beat estimates by 9 percent/37 percent/35 percent, respectively.
    7/11
    Dr Reddy's Laboratories | CMP: Rs 4,312.45 | The stock price added over 2 percent after research house Macquarie kept "outperform" rating on the stock with a target at Rs 4,915 a share as Q3 revenue/EBITDA/PAT beat estimates by 9 percent/37 percent/35 percent, respectively.
    Amara Raja Batteries | CMP: Rs 575 | The share price ended in the green after the firm registered a 53% year-on-year growth in consolidated profit at Rs 221.9 crore for quarter ended December FY23, backed by health topline and operating performance. Revenue grew by 11.5% to Rs 2,638 crore compared to year-ago period driven by healthy volume growth in the automotive sector in both OEM and Aftermarket segments.
    8/11
    Amara Raja Batteries | CMP: Rs 575 | The share price ended in the green after the firm registered a 53% year-on-year growth in consolidated profit at Rs 221.9 crore for the quarter ended December FY23, backed by healthy topline and operating performance. Revenue grew by 11.5% to Rs 2,638 crore compared to the year-ago period driven by healthy volume growth in the automotive sector in both OEM and Aftermarket segments.
    Dixon Technologies | CMP: Rs 2,728 | The scrip crashed over 18 percent after the electronics manufacturing services firm cut its FY23 revenue guidance to Rs 12,200 crore ‐Rs 12,700 crore from Rs 15,000 crore following a weak October-December quarter. The company's revenue from operations fell 22 percent year-on-year to Rs 2,405 crore while its net profit grew 13 percent to Rs 52 crore. Operating margins improved from 3.4 percent to 4.7 percent.
    9/11
    Dixon Technologies | CMP: Rs 2,728 | The scrip crashed over 18 percent after the electronics manufacturing services firm cut its FY23 revenue guidance to Rs 12,200 crore ‐Rs 12,700 crore from Rs 15,000 crore following a weak October-December quarter. The company's revenue from operations fell 22 percent year-on-year to Rs 2,405 crore while its net profit grew 13 percent to Rs 52 crore. Operating margins improved from 3.4 percent to 4.7 percent.
    Blue Dart | CMP: Rs 6,540 | The stock declined 3 percent after the firm reported a 28.2% year-on-year decline in consolidated profit at Rs 88.66 crore for quarter ended December FY23, impacted by weak operating performance. Revenue for the quarter however grew by 6.6% to Rs 1,337 crore compared to year-ago period. At the operating level, EBITDA drops 16.7% YoY to Rs 228 crore with margin falling 470 bps to 17.1% compared to year-ago period.
    10/11
    Blue Dart | CMP: Rs 6,540 | The stock declined 3 percent after the firm reported a 28.2% year-on-year decline in consolidated profit at Rs 88.66 crore for the quarter ended December FY23, impacted by weak operating performance. Revenue for the quarter however grew by 6.6% to Rs 1,337 crore compared to the year-ago period. At the operating level, EBITDA drops 16.7% YoY to Rs 228 crore with the margin falling 470 bps to 17.1% compared to the year-ago period.
    Cipla | CMP: Rs 1,049.95 | The share ended in the green on January 27. The company posted a consolidated profit after tax (PAT) of Rs 801 crore for the quarter, increasing by 10 percent from Rs 729 crore reported in the same quarter last year. It had reported a profit of Rs 789 crore in the September'22 quarter. Consolidated revenue came in higher YoY by 6 percent at Rs 5,801 crore, compared to Rs 5,479 crore logged in December 2021 quarter. Revenue in Q2FY23 stood at Rs 5,829 crore.
    11/11
    Cipla | CMP: Rs 1,049.95 | The share ended in the green on January 27. The company posted a consolidated profit after tax (PAT) of Rs 801 crore for the quarter, up 10 percent from Rs 729 crore reported in the same quarter last year. It had reported a profit of Rs 789 crore in the September'22 quarter. Consolidated revenue came in higher YoY by 6 percent at Rs 5,801 crore, compared to Rs 5,479 crore logged in December 2021 quarter. Revenue in Q2FY23 stood at Rs 5,829 crore.